dual gip/glp-1 receptor agonist Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research The Emerging Role of Dual
Description
Head-to-head trials comparing different GLP-1 agonists and the newer dual/triple agonists are needed to provide clarity for clinical decision making [92]
Pi-SunyerXAstrupAFujiokaKGreenwayFHalpernAKrempfMet alA randomized, controlled trial of 3.0 mg of liraglutide in weight management
Clements, O
Slows Gastric Emptying GLP-1 medications slow the rate at which the stomach empties, suppressing appetite and leading to subsequent weight loss
